PLEKHA5 and breast carcinoma: To further investigate the metastatic function of mutated PLEKHA5 in human breast cancer, we knocked out PLEKHA5 in GFP-labeled BRCA1-WT MDA-MB-231 cells (231-GFP) (Fig. 6f; Supplementary Fig. 6f).